Castle Biosciences (NASDAQ:CSTL) reported its Q1 earnings results on Wednesday, May 3, 2023 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Castle Biosciences missed estimated earnings by 23.6%, reporting an EPS of $-1.1 versus an estimate of $-0.89.
Revenue was up $15.19 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.06 which was followed by a 9.21% drop in the share price the next day.
Here’s a look at Castle Biosciences’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.84 | -0.88 | -0.76 | -0.71 |
| EPS Actual | -0.78 | -0.77 | -0.77 | -0.97 |
| Revenue Estimate | 37.16M | 34.75M | 28.37M | 25.21M |
| Revenue Actual | 38.34M | 37.01M | 34.84M | 26.85M |
To track all earnings releases for Castle Biosciences visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
